Clinical trials
Phase 1 Hypoglycemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 2 |
| 2013 | 5 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 6 |
| Terminated | 5 |
| Withdrawn | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 4 |
| University of Maryland, Baltimore | 4 |
| Baylor Research Institute | 3 |
| The University of Texas Health Science Center at San Antonio | 3 |
| Yale University | 3 |
| Zealand Pharma | 3 |
| University of Pennsylvania | 2 |
| Alpha Republic GmbH | 1 |
| Areeg El-Gharbawy | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypoglycemia | 48 |
| Diabetes Mellitus, Type 1 | 15 |
| Diabetes Mellitus | 7 |
| Hyperglycemia | 6 |
| Diabetes Mellitus, Type 2 | 4 |
| Insulin Resistance | 3 |
| Autoimmune Diseases | 1 |
| Brain Neoplasms | 1 |
| Burns | 1 |
| Congenital Hyperinsulinism | 1 |
Trials
Showing 51 to 48 of 48. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.